* Results indicated that RAI therapy is associated with higher rates of achieving hypothyroid status compared to ATDs, particularly significant for patients treated for over 24 months.
* The cost analysis showed that RAI therapy is more economical per patient after 12 months of treatment compared to continuing with ATDs.